SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (891)1/15/1999 5:37:00 PM
From: Dan Spillane  Read Replies (1) | Respond to of 2539
 
In particular, the small market capitalization relative to the big drug companies and/or DuPont makes a hostile bid increasingly possible.



To: Anthony Wong who wrote (891)1/15/1999 5:56:00 PM
From: jopawa  Read Replies (1) | Respond to of 2539
 
I'd like to buy more also, but I've already got 500 and I'm a little nervous that Merck will get the label that we were hoping for when Viox gets approval. If they do we are going to get slammed, but if they get the same label we'll have less pressure on the stock. Needless to say, if why wanted this much volatility I would have bought a biotech, it sure trades like one recently.

John



To: Anthony Wong who wrote (891)1/15/1999 8:05:00 PM
From: twt  Read Replies (1) | Respond to of 2539
 
Man, more not-so-good news for MTC.

Does MTC have any major drugs coming out this year?

p/s: I sold my position @$45 last week. Made a little. MAy jump in again if it keeps dropping.

Have a good MLK Holiday.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News